Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A C677T mutation in the methylenetetrahydrofolate reductase gene modifies serum cysteine in dialysis patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation - 1 Nov 2000

Kimura H, Gejyo F, Suzuki S, Takeda T, Miyazaki R, Yoshida H

Abstract excerpt

Patients undergoing hemodialysis have impaired metabolism of such sulfur-containing amino acids as cysteine (Cys) and homocysteine (Hcy), which may lead to accelerated atherosclerosis. Considering that Cys is mainly synthesized from Hcy, a common C677T mutation in the methylenetetrahydrofolate re...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analysis of Variance
Share to Cysteine
Share to Homocysteine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Failure, Chronic

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Oxidoreductases Acting on CH-NH Group Donors

Share to Regression Analysis

Share to Renal Dialysis

Source

Identifiers

PMID: 11054348
DOI: 10.1053/ajkd.2000.19085

Genes

MTHFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-11054348-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A C677T mutation in the methylenetetrahydrofolate reductase gene modifies serum cysteine in dialysis patients.PMID 11054348Read ↗

The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients.Semantic proximity Read ↗

Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.Semantic proximity Read ↗

Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis.Semantic proximity Read ↗

Hyperhomocysteinemia is related to residual glomerular filtration and folate, but not to methylenetetrahydrofolate-reductase and methionine synthase polymorphisms, in supplemented end-stage renal disease patients undergoing hemodialysis.Semantic proximity Read ↗

[Methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in hemodialysing patients].Semantic proximity Read ↗

Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients.Semantic proximity Read ↗

An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease.Semantic proximity Read ↗

Prevalence of methylenetetrahydrofolate gene (MTHFR) C677T polymorphism among chronic hemodialysis patients and its association with cardiovascular disease: a cross-sectional analysis.Semantic proximity Read ↗

The C677T methylenetetrahydrofolate reductase gene mutation in hemodialysis patients.Semantic proximity Read ↗

[Some aspects of homocysteine metabolism in hemodialysis patients].Semantic proximity Read ↗

Increased prevalence of combined MTR and MTHFR genotypes among individuals with severely elevated total homocysteine plasma levels.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.